Last updated: July 12, 2021
Sponsor: Huazhong University of Science and Technology
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT04972877
TJ-IRB20190620
Ages 18-40 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age < 40, will undergo IVF-ET;
- Low ovarian reserve: Antral follicle count (AFC)<7, or AMH<1.1ng/ml; or has a historyof poor ovarian response: in the last hyper stimulation cycle, the number of retrievedoocytes<3;
- Spouse' semen examination is normal, or after semen prewash can reach the standard ofcommon IVF or Intracytoplasmic Sperm Injection(ICSI).
Exclusion
Exclusion Criteria:
- Male with azoospermia;
- Male/female's chromosome is abnormal;
- Adenomyosis, uterine fibroids, endometrial polyps, scar uterine, reproductive systemtuberculosis, oviduct effusion, pelvic lesions such as ovarian endometriosis cyst ortumor;
- Female has other endocrine disease: thyroid diseases, hyperprolactinemia, insulinresistance, diabetes, adrenal diseases, etc.
- Definitively diagnosed autoimmune diseases such as systemic lupus erythematosus,rheumatoid arthritis, antiphospholipid syndrome;
- Other pathogenesis that leads to recurrent miscarriage or agnogenic recurrentmiscarriage;
- A history of cancer and has received radiotherapy and chemotherapy;
- Had acupuncture treatment in recent 3 months;
- Unwilling to sign the informed consent of this study.
Study Design
Total Participants: 338
Study Start date:
September 09, 2019
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Department of Integrated Traditional Chinese and Western Medicine Tongji hospital of Huazhong University of Science and Technology
Wuhan, Hubei 027
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.